| Year |
Citation |
Score |
| 2019 |
Serper M, Evon DM, Stewart PW, Lok AS, Amador J, Reeve BB, Golin CE, Fried MW, Reddy KR, Sterling RK, Sarkar S, Di Bisceglie AM, Lim JK, Nelson DR, Reau N. Medication Non-adherence in a Prospective, Multi-center Cohort Treated with Hepatitis C Direct-Acting Antivirals. Journal of General Internal Medicine. PMID 31659661 DOI: 10.1007/S11606-019-05394-9 |
0.354 |
|
| 2019 |
Evon DM, Sarkar S, Amador J, Lok AS, Sterling RK, Stewart PW, Reeve BB, Serper M, Reau N, Rajender Reddy K, Di Bisceglie AM, Nelson DR, Golin CE, Lim JK, Fried MW. Patient-reported symptoms during and after direct acting antiviral therapies for chronic hepatitis C: The PROP UP Study. Journal of Hepatology. PMID 31096006 DOI: 10.1016/J.Jhep.2019.04.016 |
0.35 |
|
| 2019 |
Mokkarala S, Johnson C, Sarkar S, Rudas RJ. Family Practitioner-Directed Hepatitis C Therapy With Direct-Acting Antivirals Achieves High-Sustained Virologic Response in Prison Population. Journal of Correctional Health Care : the Official Journal of the National Commission On Correctional Health Care. 1078345819832875. PMID 30866706 DOI: 10.1177/1078345819832875 |
0.33 |
|
| 2019 |
Mordaunt CE, Kieffer DA, Shibata NM, Członkowska A, Litwin T, Weiss KH, Zhu Y, Bowlus CL, Sarkar S, Cooper S, Wan YY, Ali MR, LaSalle JM, Medici V. Epigenomic signatures in liver and blood of Wilson disease patients include hypermethylation of liver-specific enhancers. Epigenetics & Chromatin. 12: 10. PMID 30709419 DOI: 10.1186/S13072-019-0255-Z |
0.326 |
|
| 2019 |
Sarkar S, Corwin MT, Olson KA, Stewart SL, Liu CH, Badawi RD, Wang G. Pilot Study to Diagnose Nonalcoholic Steatohepatitis With Dynamic F-FDG PET. Ajr. American Journal of Roentgenology. 1-9. PMID 30673340 DOI: 10.2214/Ajr.18.20012 |
0.316 |
|
| 2019 |
Kuo A, Liu CH, Spencer B, Durbin-Johnson B, Corwin M, Wang G, Sarkar S. THU-321-Fluorodeoxyglucose perfusion and uptake in abdominal organs is associated with hepatic disease state in patients with nonalcoholic fatty liver disease Journal of Hepatology. 70. DOI: 10.1016/S0618-8278(19)30584-5 |
0.342 |
|
| 2018 |
Kuftinec G, Loehfelm T, Corwin M, Durbin-Johnson B, Candido M, Hluhanich R, Sarkar S. hepatocellular carcinoma occurrence in hepatitis C cirrhotics treated with direct-acting antiviral agents. Hepatic Oncology. 5: HEP06. PMID 30302197 DOI: 10.2217/Hep-2018-0003 |
0.323 |
|
| 2018 |
Evon DM, Stewart PW, Amador J, Serper M, Lok AS, Sterling RK, Sarkar S, Golin CE, Reeve BB, Nelson DR, Reau N, Lim JK, Reddy KR, Di Bisceglie AM, Fried MW. A comprehensive assessment of patient reported symptom burden, medical comorbidities, and functional well being in patients initiating direct acting antiviral therapy for chronic hepatitis C: Results from a large US multi-center observational study. Plos One. 13: e0196908. PMID 30067745 DOI: 10.1371/Journal.Pone.0196908 |
0.368 |
|
| 2018 |
Wang T, Yang W, Karakas S, Sarkar S. NASH in Nondiabetic Endocrine Disorders. Metabolic Syndrome and Related Disorders. PMID 29873585 DOI: 10.1089/Met.2018.0044 |
0.306 |
|
| 2018 |
Wang G, Corwin MT, Olson KA, Badawi RD, Sarkar S. Dynamic PET of human liver inflammation: impact of kinetic modeling with optimization-derived dual-blood input function. Physics in Medicine and Biology. PMID 29847315 DOI: 10.1088/1361-6560/Aac8Cb |
0.301 |
|
| 2018 |
Evon DM, Amador J, Stewart P, Reeve BB, Lok AS, Sterling RK, Di Bisceglie AM, Reau N, Serper M, Sarkar S, Lim JK, Golin CE, Fried MW. Psychometric properties of the PROMIS short form measures in a U.S. cohort of 961 patients with chronic hepatitis C prescribed direct acting antiviral therapy. Alimentary Pharmacology & Therapeutics. PMID 29377191 DOI: 10.1111/Apt.14531 |
0.352 |
|
| 2017 |
Singh S, Kuftinec GN, Sarkar S. Non-alcoholic Fatty Liver Disease in South Asians: A Review of the Literature. Journal of Clinical and Translational Hepatology. 5: 76-81. PMID 28507930 DOI: 10.14218/Jcth.2016.00045 |
0.306 |
|
| 2017 |
Evon DM, Golin CE, Stewart P, Fried MW, Alston S, Reeve B, Lok AS, Sterling RK, Lim JK, Reau N, Sarkar S, Nelson DR, Rajender Reddy K, Di Bisceglie AM. Patient engagement and study design of PROP UP: A multi-site patient-centered prospective observational study of patients undergoing hepatitis C treatment. Contemporary Clinical Trials. PMID 28342989 DOI: 10.1016/J.Cct.2017.03.013 |
0.354 |
|
| 2017 |
Wang G, Corwin M, Olson K, Stewart S, Zha C, Badawi R, Sarkar S. Dynamic FDG-PET study of liver inflammation in non-alcoholic fatty liver disease Journal of Hepatology. 66. DOI: 10.1016/S0168-8278(17)31611-2 |
0.303 |
|
| 2016 |
Justice AC, Esserman D, Sarkar S, Levin FL, Skanderson M, Lim JK. Reply to: "Disparities in Hepatitis C Testing in U.S. Veterans Born 1945-1965". Journal of Hepatology. PMID 27717863 DOI: 10.1016/J.Jhep.2016.09.019 |
0.31 |
|
| 2016 |
Chak EW, Sarkar S, Bowlus C. Improving Healthcare Systems to Reduce Healthcare Disparities in Viral Hepatitis. Digestive Diseases and Sciences. PMID 27234269 DOI: 10.1007/S10620-016-4205-3 |
0.339 |
|
| 2016 |
Sarkar S, Esserman DA, Skanderson M, Levin FL, Justice AC, Lim JK. Disparities in Hepatitis C Testing in U.S. Veterans Born 1945-1965. Journal of Hepatology. PMID 27130843 DOI: 10.1016/J.Jhep.2016.04.012 |
0.324 |
|
| 2016 |
Evon DM, Wahed AS, Johnson G, Khalili M, Lisker-Melman M, Fontana RJ, Sarkar S, Reeve BB, Hoofnagle JH. Fatigue in Patients with Chronic Hepatitis B Living in North America: Results from the Hepatitis B Research Network (HBRN). Digestive Diseases and Sciences. PMID 26831489 DOI: 10.1007/S10620-015-4006-0 |
0.337 |
|
| 2015 |
Sarkar S, Mitchell KA, Lim JK, Oikonomou I, Jakab S. Colitis Following Initiation of Sofosbuvir and Simeprevir for Genotype 1 Hepatitis C. Acg Case Reports Journal. 3: 42-4. PMID 26504877 DOI: 10.14309/Crj.2015.96 |
0.349 |
|
| 2015 |
Sarkar S, Mitchell KA, Lim JK, Oikonomou I, Jakab SS. Su1412 Colitis Following Initiation of Sofosbuvir and Simeprevir for Genotype 1 Hepatitis C Gastroenterology. 148. DOI: 10.1016/S0016-5085(15)31683-8 |
0.349 |
|
| 2014 |
Rotman Y, Noureddin M, Feld JJ, Guedj J, Witthaus M, Han H, Park YJ, Park SH, Heller T, Ghany MG, Doo E, Koh C, Abdalla A, Gara N, Sarkar S, et al. Effect of ribavirin on viral kinetics and liver gene expression in chronic hepatitis C. Gut. 63: 161-9. PMID 23396509 DOI: 10.1136/Gutjnl-2012-303852 |
0.364 |
|
| 2012 |
Sarkar S, Jiang Z, Evon DM, Wahed AS, Hoofnagle JH. Fatigue before, during and after antiviral therapy of chronic hepatitis C: results from the Virahep-C study. Journal of Hepatology. 57: 946-52. PMID 22760009 DOI: 10.1016/J.Jhep.2012.06.030 |
0.35 |
|
| 2008 |
Murray JW, Sarkar S, Wolkoff AW. Single vesicle analysis of endocytic fission on microtubules in vitro. Traffic (Copenhagen, Denmark). 9: 833-47. PMID 18284582 DOI: 10.1111/J.1600-0854.2008.00725.X |
0.544 |
|
| 2007 |
Nath S, Bananis E, Sarkar S, Stockert RJ, Sperry AO, Murray JW, Wolkoff AW. Kif5B and Kifc1 interact and are required for motility and fission of early endocytic vesicles in mouse liver. Molecular Biology of the Cell. 18: 1839-49. PMID 17360972 DOI: 10.1091/Mbc.E06-06-0524 |
0.635 |
|
| 2006 |
Sarkar S, Bananis E, Nath S, Anwer MS, Wolkoff AW, Murray JW. PKCzeta is required for microtubule-based motility of vesicles containing the ntcp transporter. Traffic (Copenhagen, Denmark). 7: 1078-91. PMID 16734659 DOI: 10.1111/J.1600-0854.2006.00447.X |
0.624 |
|
| Show low-probability matches. |